Stock N1BI34 NEUROCRINE BIOSCIENCES, INC.
Add to a list
To use this feature you must be a member
Log inSign up

Insiders Neurocrine Biosciences, Inc. Sao Paulo

Equities

N1BI34

BRN1BIBDR009

Market Closed - Sao Paulo
Other stock markets
 17:24:59 28/06/2024 BST 		5-day change 1st Jan Change
38.68 BRL +12.90% Intraday chart for Neurocrine Biosciences, Inc. +5.45% +19.75%
06-13 Transcript : Neurocrine Biosciences, Inc. Presents at Goldman Sachs 45th Annual Global Healthcare Conference, Jun-13-2024 10:40 AM
06-05 Transcript : Neurocrine Biosciences, Inc. Presents at Jefferies 2024 Global Healthcare Conference, Jun-05-2024 02:30 PM

Insiders

Search
See the results
Unlock all the news on all businesses: Never miss an investment opportunity again!
100% Free Registration
Neurocrine Biosciences Insider Sold Shares Worth $5,338,565, According to a Recent SEC Filing
MT
Neurocrine Biosciences Says CEO Kevin Gorman Retiring
MT
Neurocrine founder-CEO Gorman to retire in October
RE
Neurocrine CEO set to retire
RE
Neurocrine Biosciences, Inc. Announces Dr. Kyle Gano as Director, Effective October 11, 2024
CI
Neurocrine Biosciences Announces CEO Changes
CI
Neurocrine Biosciences Insider Sold Shares Worth $297,860, According to a Recent SEC Filing
MT
Neurocrine Biosciences Insider Sold Shares Worth $4,138,436, According to a Recent SEC Filing
MT
Neurocrine Biosciences Insider Sold Shares Worth $5,576,710, According to a Recent SEC Filing
MT
Neurocrine Biosciences Insider Sold Shares Worth $420,419, According to a Recent SEC Filing
MT
Neurocrine Biosciences Insider Sold Shares Worth $922,632, According to a Recent SEC Filing
MT
Neurocrine Biosciences Insider Sold Shares Worth $1,085,388, According to a Recent SEC Filing
MT
Neurocrine Biosciences Insider Sold Shares Worth $1,987,047, According to a Recent SEC Filing
MT
Neurocrine Biosciences Insider Sold Shares Worth $376,700, According to a Recent SEC Filing
MT
Neurocrine Biosciences Insider Sold Shares Worth $313,530, According to a Recent SEC Filing
MT
Neurocrine Biosciences Insider Sold Shares Worth $290,968, According to a Recent SEC Filing
MT
Neurocrine Biosciences Insider Sold Shares Worth $359,041, According to a Recent SEC Filing
MT
Neurocrine Biosciences Insider Sold Shares Worth $737,271, According to a Recent SEC Filing
MT
Neurocrine Biosciences Insider Sold Shares Worth $270,284, According to a Recent SEC Filing
MT
Neurocrine Biosciences Insider Sold Shares Worth $352,612, According to a Recent SEC Filing
MT
No results for this search
All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Search

Announcement Date

Since

Until

  1. Stock Market
  2. Equities
  3. NBIX Stock
  4. N1BI34 Stock
  5. News Neurocrine Biosciences, Inc.
  6. Insiders